Revenue Breakdown
Composition ()
No data
Revenue Streams
Tactile Systems Technology Inc (TCMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Lymphedema products, accounting for 84.4% of total sales, equivalent to $72.38M. Another important revenue stream is Airway clearance products. Understanding this composition is critical for investors evaluating how TCMD navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Tactile Systems Technology Inc maintains a gross margin of 77.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 18.12%, while the net margin is 10.27%. These profitability ratios, combined with a Return on Equity (ROE) of 8.77%, provide a clear picture of how effectively TCMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TCMD competes directly with industry leaders such as AVNS and DRTS. With a market capitalization of $657.24M, it holds a leading position in the sector. When comparing efficiency, TCMD's gross margin of 77.62% stands against AVNS's 47.54% and DRTS's N/A. Such benchmarking helps identify whether Tactile Systems Technology Inc is trading at a premium or discount relative to its financial performance.
